BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Hong W, Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Ther 2021;6:225. [PMID: 34099630 DOI: 10.1038/s41392-021-00631-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Song W, Jia P, Ren Y, Xue J, Zhou B, Xu X, Shan Y, Deng J, Zhou Q. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics. Bioactive Materials 2023;23:80-100. [DOI: 10.1016/j.bioactmat.2022.10.026] [Reference Citation Analysis]
2 Liu L, Zhao W, Ma Q, Gao Y, Wang W, Zhang X, Dong Y, Zhang T, Liang Y, Han S, Cao J, Wang X, Sun W, Ma H, Sun Y. Functional nano-systems for transdermal drug delivery and skin therapy. Nanoscale Adv 2023;5:1527-58. [PMID: 36926556 DOI: 10.1039/d2na00530a] [Reference Citation Analysis]
3 Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, Geng F. Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease. Molecules 2023;28. [PMID: 36903581 DOI: 10.3390/molecules28052336] [Reference Citation Analysis]
4 Tanaka HY, Nakazawa T, Enomoto A, Masamune A, Kano MR. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. Cancers (Basel) 2023;15. [PMID: 36765684 DOI: 10.3390/cancers15030724] [Reference Citation Analysis]
5 Xiao G, Xu Z, Luo F. Combinational antitumor strategies of exosomes as drug carriers: Mini review. Front Pharmacol 2022;13:1107329. [PMID: 36744207 DOI: 10.3389/fphar.2022.1107329] [Reference Citation Analysis]
6 Li H, Gou R, Liao J, Wang Y, Qu R, Tang Q, Gan J, Zou L, Shi S. Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment. Acta Materia Medica 2023;2. [DOI: 10.15212/amm-2022-0039] [Reference Citation Analysis]
7 Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 2023;8:36. [PMID: 36646687 DOI: 10.1038/s41392-023-01309-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2023;52:47-96. [PMID: 36427082 DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
9 Geng S, Guo M, Zhan G, Shi D, Shi L, Gan L, Zhao Y, Yang X. NIR-triggered ligand-presenting nanocarriers for enhancing synergistic photothermal-chemotherapy. J Control Release 2023;353:229-40. [PMID: 36427657 DOI: 10.1016/j.jconrel.2022.11.039] [Reference Citation Analysis]
10 Liu H, Su YY, Jiang XC, Gao JQ. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system. Drug Deliv Transl Res 2023;13:716-37. [PMID: 36417162 DOI: 10.1007/s13346-022-01252-0] [Reference Citation Analysis]
11 Wang J, Dai D, Xie H, Li D, Xiong G, Zhang C. Biological Effects, Applications and Design Strategies of Medical Polyurethanes Modified by Nanomaterials. Int J Nanomedicine 2022;17:6791-819. [PMID: 36600880 DOI: 10.2147/IJN.S393207] [Reference Citation Analysis]
12 Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, Mubeen B, Murtaza BN, Iftikhar S, Riaz N, Kazmi I. Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials (Basel) 2022;12. [PMID: 36558344 DOI: 10.3390/nano12244494] [Reference Citation Analysis]
13 Pacheco MO, Eccles LE, Davies NA, Armada J, Cakley AS, Kadambi IP, Stoppel WL. Progress in silk and silk fiber-inspired polymeric nanomaterials for drug delivery. Front Chem Eng 2022;4. [DOI: 10.3389/fceng.2022.1044431] [Reference Citation Analysis]
14 Qiu Z, Yu Z, Xu T, Wang L, Meng N, Jin H, Xu B. Novel Nano-Drug Delivery System for Brain Tumor Treatment. Cells 2022;11. [PMID: 36497021 DOI: 10.3390/cells11233761] [Reference Citation Analysis]
15 Youden B, Jiang R, Carrier AJ, Servos MR, Zhang X. A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano 2022;16:17497-551. [PMID: 36322785 DOI: 10.1021/acsnano.2c06337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pranav, Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. J Adv Res 2022:S2090-1232(22)00250-8. [PMID: 36368516 DOI: 10.1016/j.jare.2022.11.001] [Reference Citation Analysis]
17 Tao Y, Lan X, Zhang Y, Fu C, Liu L, Cao F, Guo W. Biomimetic nanomedicines for precise atherosclerosis theranostics. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.014] [Reference Citation Analysis]
18 Xu J, Zhang Y, Liu Y, You Y, Li F, Chen Y, Xie L, Tong S, Zhou S, Liang K, Huang Y, Jiang G, Song Q, Mei N, Ma F, Gao X, Wang H, Chen J. Vitality-Enhanced Dual-Modal Tracking System Reveals the Dynamic Fate of Mesenchymal Stem Cells for Stroke Therapy. Small 2022;18:e2203431. [PMID: 36180405 DOI: 10.1002/smll.202203431] [Reference Citation Analysis]
19 Farheen J, Hosmane NS, Zhao R, Zhao Q, Iqbal MZ, Kong X. Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. Mater Today Bio 2022;16:100450. [PMID: 36267139 DOI: 10.1016/j.mtbio.2022.100450] [Reference Citation Analysis]
20 Chen Z, Chen X, Huang J, Wang J, Wang Z. Harnessing Protein Corona for Biomimetic Nanomedicine Design. Biomimetics 2022;7:126. [DOI: 10.3390/biomimetics7030126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bagasariya D, Charankumar K, Shah S, Famta P, Khatri D, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Biomimetic Nanotherapeutics: Employing Nanoghosts to fight Melanoma. Eur J Pharm Biopharm 2022:S0939-6411(22)00137-0. [PMID: 35787429 DOI: 10.1016/j.ejpb.2022.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Song W, Jia P, Zhang T, Dou K, Liu L, Ren Y, Liu F, Xue J, Hasanin MS, Qi H, Zhou Q. Cell membrane-camouflaged inorganic nanoparticles for cancer therapy. J Nanobiotechnology 2022;20:289. [PMID: 35717234 DOI: 10.1186/s12951-022-01475-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang Q, Li S, Ren J, He X, Shi H, Zhang F, Li H, Tong R. ROS-triggered nanoinducer based on dermatan sulfate enhances immunogenic cell death in melanoma. J Control Release 2022;348:22-33. [PMID: 35461966 DOI: 10.1016/j.jconrel.2022.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jiang Y, Li J, Xue X, Yin Z, Xu K, Su J. Engineered extracellular vesicles for bone therapy. Nano Today 2022;44:101487. [DOI: 10.1016/j.nantod.2022.101487] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
25 Pandey J, Dubey R, Kate A, Prasad B, Sinha A, Mishra MS. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement. Drug Res (Stuttg). [DOI: 10.1055/a-1824-4619] [Reference Citation Analysis]
26 Halimu G, Zhang Q, Liu L, Zhang Z, Wang X, Gu W, Zhang B, Dai Y, Zhang H, Zhang C, Xu M. Toxic effects of nanoplastics with different sizes and surface charges on epithelial-to-mesenchymal transition in A549 cells and the potential toxicological mechanism. Journal of Hazardous Materials 2022;430:128485. [DOI: 10.1016/j.jhazmat.2022.128485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Świętek M, Ma YH, Wu NP, Paruzel A, Tokarz W, Horák D. Tannic Acid Coating Augments Glioblastoma Cellular Uptake of Magnetic Nanoparticles with Antioxidant Effects. Nanomaterials (Basel) 2022;12:1310. [PMID: 35458018 DOI: 10.3390/nano12081310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ye J, Yu B, Hu H, Zhou D, Jin Q, Ji J, Tang Z. Verteporfin-loaded supramolecular micelles for enhanced cisplatin-based chemotherapy via autophagy inhibition. J Mater Chem B 2022;10:2670-9. [PMID: 35043820 DOI: 10.1039/d1tb02583j] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Das R, Kanjilal P, Medeiros J, Thayumanavan S. What's Next after Lipid Nanoparticles? A Perspective on Enablers of Nucleic Acid Therapeutics. Bioconjug Chem 2022. [PMID: 35377622 DOI: 10.1021/acs.bioconjchem.2c00058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lai X, Liu XL, Pan H, Zhu MH, Long M, Yuan Y, Zhang Z, Dong X, Lu Q, Sun P, Lovell JF, Chen HZ, Fang C. Light-Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo-, Antiangiogenic, and Anti-MDSC Therapy in Melanoma. Adv Mater 2022;34:e2106682. [PMID: 34989039 DOI: 10.1002/adma.202106682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
31 Yang W, Wang L, Fang M, Sheth V, Zhang Y, Holden AM, Donahue ND, Green DE, Frickenstein AN, Mettenbrink EM, Schwemley TA, Francek ER, Haddad M, Hossen MN, Mukherjee S, Wu S, DeAngelis PL, Wilhelm S. Nanoparticle Surface Engineering with Heparosan Polysaccharide Reduces Serum Protein Adsorption and Enhances Cellular Uptake. Nano Lett 2022. [PMID: 35166110 DOI: 10.1021/acs.nanolett.2c00349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
32 Ding X, Sun X, Cai H, Wu L, Liu Y, Zhao Y, Zhou D, Yu G, Zhou X. Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy. Front Oncol 2021;11:786913. [PMID: 35070992 DOI: 10.3389/fonc.2021.786913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Luo Y, Zhang X, Chen R, Li R, Liu Y, Zhang J, Liu Q, Si M, Liu J, Wu B, Wang X, Wu S, Zhang Y, Zhang X, Guo D, He X, Pan T, Zhang H. USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID. Signal Transduct Target Ther 2022;7:7. [PMID: 34983926 DOI: 10.1038/s41392-021-00858-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Hu T, Qin Z, Shen C, Gong HL, He ZY. Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy. Front Bioeng Biotechnol 2021;9:786621. [PMID: 34900973 DOI: 10.3389/fbioe.2021.786621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
35 Zhao Y, Tian C, Wu K, Zhou X, Feng K, Li Z, Wang Z, Han X. Vancomycin-Loaded Polycaprolactone Electrospinning Nanofibers Modulate the Airway Interfaces to Restrain Tracheal Stenosis. Front Bioeng Biotechnol 2021;9:760395. [PMID: 34869271 DOI: 10.3389/fbioe.2021.760395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Minati L, Maniglio D, Benetti F, Chiappini A, Speranza G. Multimodal Gold Nanostars as SERS Tags for Optically-Driven Doxorubicin Release Study in Cancer Cells. Materials (Basel) 2021;14:7272. [PMID: 34885427 DOI: 10.3390/ma14237272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Wang Y, Xu X, Chen X, Li J. Multifunctional Biomedical Materials Derived from Biological Membranes. Adv Mater 2021;:e2107406. [PMID: 34739155 DOI: 10.1002/adma.202107406] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
38 Zhao Z, Yang S, Zhou A, Li X, Fang R, Zhang S, Zhao G, Li P. Small Extracellular Vesicles in the Development, Diagnosis, and Possible Therapeutic Application of Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:732702. [PMID: 34527593 DOI: 10.3389/fonc.2021.732702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Parés M, Fornaguera C, Vila-Julià F, Oh S, Fan SHY, Tam YK, Comes N, Vidal F, Martí R, Borrós S, Barquinero J. Preclinical Assessment of a Gene-Editing Approach in a Mouse Model of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2021;32:1210-23. [PMID: 34498979 DOI: 10.1089/hum.2021.152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Beh CY, Prajnamitra RP, Chen LL, Hsieh PC. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. Molecules 2021;26:5052. [PMID: 34443638 DOI: 10.3390/molecules26165052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]